000 01465 a2200397 4500
005 20250516190905.0
264 0 _c20140305
008 201403s 0 0 eng d
022 _a1941-9260
024 7 _a10.3810/pgm.2014.01.2724
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMooney, David
245 0 0 _aUpdate in systemic therapy of urologic malignancies.
_h[electronic resource]
260 _bPostgraduate medicine
_cJan 2014
300 _a44-54 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAndrogen Antagonists
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMicrotubules
_xdrug effects
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aRadiopharmaceuticals
_xtherapeutic use
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
700 1 _aPaluri, Ravikumar
700 1 _aMehta, Amitkumar
700 1 _aGoyal, Jatinder
700 1 _aSonpavde, Guru
773 0 _tPostgraduate medicine
_gvol. 126
_gno. 1
_gp. 44-54
856 4 0 _uhttps://doi.org/10.3810/pgm.2014.01.2724
_zAvailable from publisher's website
999 _c23420305
_d23420305